Clinical Trials Browser

Has announcements × Glioblastoma × TIC10 compound × Clear all

NCT02525692 2024-12-24

Oral ONC201 in Adult Recurrent Glioblastoma

Phase 2 Terminated

84 enrolled 14 charts 1 FDA

Glioblastoma